Cerus
CERS
#7525
Rank
โ‚ฌ0.34 B
Marketcap
1,80ย โ‚ฌ
Share price
5.53%
Change (1 day)
5.83%
Change (1 year)

Cerus (CERS) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ0.18 Billion

According to Cerus's latest financial reports the company's total assets are โ‚ฌ0.18 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Cerus - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ0.19 B7.93%
2023-12-31โ‚ฌ0.17 B-12.02%
2022-12-31โ‚ฌ0.20 B-3.05%
2021-12-31โ‚ฌ0.20 B16.5%
2020-12-31โ‚ฌ0.18 B21.82%
2019-12-31โ‚ฌ0.14 B3.42%
2018-12-31โ‚ฌ0.14 B74.51%
2017-12-31โ‚ฌ81.87 M-16.77%
2016-12-31โ‚ฌ98.37 M-22.84%
2015-12-31โ‚ฌ0.12 B89.61%
2014-12-31โ‚ฌ67.23 M11.36%
2013-12-31โ‚ฌ60.37 M63.26%
2012-12-31โ‚ฌ36.98 M5.86%
2011-12-31โ‚ฌ34.93 M-3.53%
2010-12-31โ‚ฌ36.21 M50.42%
2009-12-31โ‚ฌ24.07 M-28.91%
2008-12-31โ‚ฌ33.86 M-36.78%
2007-12-31โ‚ฌ53.56 M-38.97%
2006-12-31โ‚ฌ87.77 M77.25%
2005-12-31โ‚ฌ49.51 M-34.2%
2004-12-31โ‚ฌ75.25 M-20.02%
2003-12-31โ‚ฌ94.09 M34.84%
2002-12-31โ‚ฌ69.78 M-51.95%
2001-12-31โ‚ฌ0.14 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Haemonetics
HAE
โ‚ฌ2.09 B 1,034.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ5.29 M-97.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
โ‚ฌ36.64 B 19,746.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
โ‚ฌ0.10 B-43.86%๐Ÿ‡บ๐Ÿ‡ธ USA